(454-4270 g). Ophthalmic review was undertaken in 20 infants (81%), three infants died, two lost to follow-up and two to be reviewed. Of those reviewed 11 were term or near-term (34-40 weeks). First examination was normal in all of them and at 2 month follow-up (0.5-36 months), 9 had normal examination with 2 (18%) infants developing unrelated conditions (one congenital motor nystagmus and one infantile esotropia). Amongst the 9 (45%) premature infants (<34/40) reviewed, ROP was found in 5 (56%), 3 at initial examination, and 2 during follow-up. Three of these infants required laser therapy. Infants with ROP were extremely preterm (<28/40) and low birth weight (455-568 g).
Judith
Lumley Centre, La Trobe University, Melbourne, Victoria, Australia Introduction: The aim was to explore obstetricians' experiences and views on the role of obstetric ultrasound in clinical management of pregnancies, and in situations where maternal and fetal health interests conflict.
Methods: Interviews were held with physicians (N = 20) working in maternity care in five different regions of Norway in 2015 as part of the CROss Country Ultrasound Study (CROCUS) .
Results: Three categories developed during analyses. 'A conservative approach to pregnancy ultrasound and prenatal diagnosis' revealed divergent views in relation to Norwegian policies to ultrasound screening and prenatal diagnosis, with Down syndrome screening portrayed as a delicate and frequently debated issue. 'Ultrasound's influence on the view of the fetus' illuminated how ultrasound influenced expectant parents' view of, and bonding with the fetus, as well as their own identity as expectant parents. Physicians described how ultrasound was sometimes used as a means of comfort when complications occurred. Furthermore, a common view was that the fetus became a 'patient' once examined by ultrasound. 'The complexity of information and counselling' revealed how physicians' balanced the medical and social aspects of the ultrasound examination, the difficulties of counselling in situations of uncertain findings, and views of increasing ethical challenges with developments in prenatal diagnosis.
Conclusions: Norwegian regulations about the use of ultrasound during pregnancy were not unanimously supported by these physicians in maternity care. It will also be important to consider the views of pregnant women in further discussions of the level of provision of these services. Background: Foetal and neonatal hepatic haemangiomas are rare, with current literature documenting an incidence of approximately 5% of tumours in infants. Antenatal identification of these lesions is becoming more possible with routine ultrasound surveillance in pregnancy.
Method: A database search was conducted for case reports in the literature pertaining to diagnosis and management foetal hepatic vascular lesions.
Results: There is debate in the literature regarding the true diagnosis of vascular hepatic lesions identified on ultrasound antenatally. The suggestion is that it is difficult to classify foetal hepatic vascular lesions prior to birth, as it requires differentiation between benign hepatic haemangioma, pre-malignant hepatic haemangioendothelioma, and hepatic arterio-venous malformation.
Therefore, antenatal surveillance of these lesions aims to monitor for foetal compromise. Initial evaluation includes assessment of the size, number, location, and vascularity of the lesion. The majority of haemangiomas will follow a classical course of shortterm proliferation followed by involution, mainly after birth. However, a small subgroup have been documented to develop complications antenatally. These haemangiomas are larger, greater than 40 mm, and may have identifiable feeding vessels and high flow velocity that could result in significant arterovenous shunting. There are reports of complications such as cardiac failure with hydrops, thrombocytopenia, haemolytic anaemia and consumptive coagulopathy.
Conclusion: Hepatic haemangiomas are rare lesions which may be identified antenatally on routine ultrasound surveillance, though limitations on accuracy of diagnosis make antenatal management challenging. Therefore, ongoing antenatal ultrasound monitoring has been recommended. The majority of these lesions will remain asymptomatic and regress in early childhood. 
Results:
We identified 4 cases of NL with an incidence of 1:51,402 live births. Three were born preterm, of which 2 were male. There was history of maternal fever in all cases. Three out of 4 mothers presented with reduced fetal movements. All 4 cases had non-reassuring foetal status in cardiotocography and the liquor was meconium stained, requiring positive pressure ventilation and administration of surfactant. Two placental swabs were positive for LM and 3 had histopathological evidence of chorioamnionitis. Two maternal blood cultures and all infants' blood cultures were positive for LM. LM identified in blood cultures was sensitive to Ampicillin and the response to a combination of Ampicillin with Gentamicin was adequate. Two of these infants had severe hypotension requiring multiple inotropes and inhaled nitric oxide for severe pulmonary hypertension. All infants survived. Two were lost to follow up and the rest had normal neuro-developmental outcome at 2 years of age.
Conclusion: This study shows that congenital listeriosis is rare in Singapore. Outcome is extremely favorable with early diagnosis and treatment with appropriate antibiotics, hemodynamic and respiratory support. Ritchie Centre Background: Maternal obesity (BMI > 25) and gestational diabetes (GDM) are significant health issues affecting 20% (obesity) and~15% (GDM) of all pregnancies. Both conditions are known to dysregulate placental metabolism. The creatine kinase circuit is a spatial and temporal ATP buffer within the placenta. Whether this critical pathway is altered by maternal obesity or GDM is unknown. This study examined the mRNA expression of the creatine transporter and synthesising enzymes in placentae of women with pre-existing obesity as well as women who developed GDM.
MATERNAL OBESITY AND GESTATIONAL DIABETES MAY IMPACT CREATINE AVAILABILITY TO THE TERM
Method: Term human placenta samples were collected from lean controls (n = 18); obese women without GDM (n = 14); lean (n = 10) and obese (n = 18) women with GDM managed by diet; and lean (n = 20) and obese (n = 14) women with GDM managed with insulin. cDNA was generated and relative mRNA expression of the creatine transporter (SLC6A8) and synthesising enzymes arginine:glycine aminotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT) was assessed using Fluidigm DNAseq and TaqMan chemistry. Data were analysed by TwoWay ANOVA with Sidak's multiple comparisons.
Results: Compared to lean controls, maternal obesity significantly down-regulated mRNA expression of SLC6A8 (p < 0.01) and AGAT (p < 0.01), the rate-limiting enzyme of creatine synthesis. Insulin treatment of GDM was associated with upregulation of placental SLC6A8 mRNA (p < 0.001), compared to lean controls. GDM was also associated with up-regulation of GAMT mRNA (p < 0.05), irrespective of maternal BMI or management strategy.
Conclusions: Maternal obesity and GDM may impact creatine availability and placental ATP turnover by the creatine kinase circuit, contributing to the dysregulated placental metabolism observed with maternal obesity and GDM. Children's Hospital at Westmead, the 2 Cerebral Palsy Alliance Background: Infants who have undergone major neonatal cardiac surgery have delays in their neurodevelopmental outcomes at 1 and 3 years of age. The aim of this research was to investigate the ability of 1 year outcomes to predict outcomes at three years following early cardiac surgery.
EARLY PREDICTION OF DEVELOPMENTAL OUTCOMES
Method: Cardiac surgical infants who were enrolled in the Development After Infant Surgery (DAISy) study and had complete Bayley Scale of Infant and Toddler Development III (BSID-III) results from the 1 and 3 year assessments were included in the analysis. The outcomes and trajectories of 159 children were classified as below average (< −1 SD), within the average range, or above average (>1 SD). Analysis included group differences, validity and prediction.
Results: The developmental outcomes at three years in all five domains improved between 35% and 58% for those who scored below average at one. Conversely many who performed above average at 1, scored poorer at 3 in all domains (57%-90%). Sensitivity and negative predictive values were high for all domains of the BSID-III, which reflected the changes between 1 and 3. Specificity and negative predictive values varied between domains from very low to high. Maternal education, birth weight, outcome at 1 on the BSID-III and Apgars at 5 was statistically significant predictors.
Conclusions: The bidirectional changes in outcomes for all domains influenced the predictive validity of the BSID-III. Although the predictors were statistically significant, they all remained weak at predicting outcome at 3. This highlights the importance of ongoing follow up. Future research should consider the impact of interventions between assessments. Northern Hospital, Epping, Australia Background: Although milk fortification for low birth weight (LBW) babies is standard practice, commencement criteria varies widely and few studies have evaluated comparative outcomes.
EARLIER FORTIFICATION FOR LOW BIRTH WEIGHT BABIES -DOES IT MAKE
Methods: LBW babies admitted to SCN at the Northern Hospital between October 2014 and June 2016, were randomly assigned to 2 groups (F80, n = 45 ; F160, n = 42), commencing
